• 135568+ Medical Conferences
  • 251 Specialties
  • 10441 Organizers
  • 150899 Speakers
  • 155 Countries
  • 4525 Cities
CME Conference Registrations Sold
Home  >  Speakers  >  Michel Janicot
Michel Janicot

Michel Janicot

Founder, Chief, Director | London, England    United Kingdom
Biochemistry And Molecular Genetics, Molecular Biology
Molecular Biology, Biochemistry And Molecular Genetics,...More
Spoken at 2 events

Biography :

Dr. Michel Janicot has served as head of preclinical research & development since July 2012. He has over 20 years of pharmaceutical industry experience in oncology R&D. Prior to joining the company, he was Senior Director at Janssen R&D (Johnson&Johnson) located in Beerse, Belgium and then founded his own consulting firm (JMi ONConsulting). He has managed large multidisciplinary teams for the worldwide preclinical and early clinical development of both small molecules and biologics drug candidates for oncology intervention.
His management expertise, leadership, and strategic vision, combined with extensive experience with large pharma companies such as Johnson&Johnson and Sanofi (formerly Rhône-Poulenc Rorer), covers a large scope of the drug development process – from discovery to early clinical development. He has a doctorate in biochemistry from the University Paris VII, France, obtained in 1988 and did a postdoctoral training at The Johns Hopkins University, Baltimore

For speaker's contact information - Contact us


Biochemistry and Molecular Genetics, Molecular Biology

Interested Topics

Molecular Biology, Biochemistry and Molecular Genetics, Oncology, Pharmaceutical Industry, Pediatric Oncology, Research and Development, Drug Development, Immunology, Neuroscience, Translational Medicine, Biomarkers

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Send Message